These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 9743354

  • 21. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D, Amrani A, Verdaguer J, Bou S, Santamaria P.
    J Immunol; 1999 Apr 15; 162(8):4627-36. PubMed ID: 10202002
    [Abstract] [Full Text] [Related]

  • 22. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
    Wang D, Hill JA, Cairns E, Bell DA.
    J Autoimmun; 2002 Mar 15; 18(2):95-103. PubMed ID: 11908942
    [Abstract] [Full Text] [Related]

  • 23. Citrullination of self-proteins and autoimmunity.
    Rubin B, Sønderstrup G.
    Scand J Immunol; 2004 Mar 15; 60(1-2):112-20. PubMed ID: 15238080
    [Abstract] [Full Text] [Related]

  • 24. Mixed-haplotype MHC class II molecules select functional CD4+ T cells.
    Silk JD, Schoendorf D, Bartok I, Chai JG, Gray D, Simpson E, Dyson J.
    Mol Immunol; 2005 Jun 15; 42(10):1129-39. PubMed ID: 15829303
    [Abstract] [Full Text] [Related]

  • 25. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
    Singh N, Van Kaer L.
    J Immunol; 1999 Oct 01; 163(7):3583-91. PubMed ID: 10490950
    [Abstract] [Full Text] [Related]

  • 26. Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers.
    Xu M, Lu X, Sposato M, Zinckgraf JW, Wu S, von Hofe E.
    Vaccine; 2009 Jul 23; 27(34):4641-7. PubMed ID: 19520206
    [Abstract] [Full Text] [Related]

  • 27. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.
    Ge X, Piganelli JD, Tse HM, Bertera S, Mathews CE, Trucco M, Wen L, Rudert WA.
    Diabetes; 2006 Dec 23; 55(12):3455-62. PubMed ID: 17130492
    [Abstract] [Full Text] [Related]

  • 28. Low-avidity recognition by CD4+ T cells directed to self-antigens.
    Gebe JA, Falk BA, Rock KA, Kochik SA, Heninger AK, Reijonen H, Kwok WW, Nepom GT.
    Eur J Immunol; 2003 May 23; 33(5):1409-17. PubMed ID: 12731068
    [Abstract] [Full Text] [Related]

  • 29. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, Jackson DC, Ladhams J, Allison J, McCluskey J.
    J Immunol; 2009 Jun 15; 182(12):7440-50. PubMed ID: 19494267
    [Abstract] [Full Text] [Related]

  • 30. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK, Culbertson N, Rich C, LaTocha D, Buenafe AC, Huan J, Link J, Wands JM, Born WK, Offner H, Bourdette DN, Burrows GG, Vandenbark AA.
    J Neurosci Res; 2004 Sep 01; 77(5):670-80. PubMed ID: 15352213
    [Abstract] [Full Text] [Related]

  • 31. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells.
    Shen X, König R.
    Cell Mol Biol (Noisy-le-grand); 2001 Feb 01; 47(1):87-96. PubMed ID: 11292263
    [Abstract] [Full Text] [Related]

  • 32. Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.
    Lüthje K, Cramer SO, Ehrlich S, Veit A, Steeg C, Fleischer B, Bonin Av, Breloer M.
    Eur J Immunol; 2006 Aug 01; 36(8):2035-45. PubMed ID: 16841299
    [Abstract] [Full Text] [Related]

  • 33. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
    Caveno J, Zhang Y, Motyka B, Teh SJ, Teh HS.
    J Immunol; 1999 Aug 01; 163(3):1222-9. PubMed ID: 10415017
    [Abstract] [Full Text] [Related]

  • 34. Quantitative but not qualitative variation in MHC class II alters CD4 interaction and influences T cell repertoire formation.
    Fuller-Espie SL, Murphy GA, Brett SJ, Lechler RI.
    Cell Immunol; 1997 Apr 10; 177(1):49-61. PubMed ID: 9140095
    [Abstract] [Full Text] [Related]

  • 35. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
    Lo-Man R, Martineau P, Hofnung M, Leclerc C.
    Cell Immunol; 1996 Sep 15; 172(2):180-91. PubMed ID: 8964079
    [Abstract] [Full Text] [Related]

  • 36. Recognition of altered self major histocompatibility complex molecules modulated by specific peptide interactions.
    Nepom GT, Ou D, Lybrand TP, DeWeese C, Domeier ME, Buckner JH, Mitchell LA, Tingle AJ.
    Eur J Immunol; 1996 Apr 15; 26(4):949-52. PubMed ID: 8625994
    [Abstract] [Full Text] [Related]

  • 37. [CD4+T cells restricted by DQ not by DR support CD8+T cells to grow].
    Kamikawaji N.
    Fukuoka Igaku Zasshi; 1990 Feb 15; 81(2):88-96. PubMed ID: 2328939
    [Abstract] [Full Text] [Related]

  • 38. Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules.
    Zeng G, Touloukian CE, Wang X, Restifo NP, Rosenberg SA, Wang RF.
    J Immunol; 2000 Jul 15; 165(2):1153-9. PubMed ID: 10878395
    [Abstract] [Full Text] [Related]

  • 39. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
    Wen L, Chen NY, Tang J, Sherwin R, Wong FS.
    J Clin Invest; 2001 Apr 15; 107(7):871-80. PubMed ID: 11285306
    [Abstract] [Full Text] [Related]

  • 40. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response.
    Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS.
    Proc Natl Acad Sci U S A; 1994 Jun 21; 91(13):6151-5. PubMed ID: 8016129
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.